Thurston J. Hamlette
Thurston J. Hamlette focuses his practice on corporate and securities matters, primarily representing issuers and investment banks in public and private corporate finance transactions. He handles equity and debt securities registered offerings, Rule 144A/Regulation S offerings, initial public offerings, follow-on and secondary equity offerings, high-yield and investment-grade debt offerings, special-purpose acquisition company (SPAC) transactions, and liability management transactions. Thurston counsels on US Securities and Exchange Commission (SEC) regulations and disclosure requirements; Securities Exchange Act of 1934 reporting obligations; annual meeting and proxy-related issues; corporate governance; environmental, social, and governance (ESG); and general corporate matters.
Thurston is committed to keeping clients up to date on SEC regulatory developments and disclosure issues and trends. Thurston advances the firm’s thought leadership on these topics as a presenter in the Morgan Lewis Public Company Academy and as a LawFlash contributor.
Capital Markets Transactions
Equity
- The underwriters of a $150 million initial public offering of a blank check company incorporated as a Cayman Islands exempted company
- The underwriter of a $100 million confidentially marketed public offering of common stock by a biotechnology company
- The underwriters of a $230 million public offering of common stock by a biotechnology company
- The placement agents in connection with Critical Metals Corp.’s $24.5 million PIPE financing of units, each consisting of an ordinary share and a warrant exercisable for ordinary shares
- Eastdil Secured Advisors LLC, as the placement agent, in a private secondary transaction of 225,600 shares of a commercial real estate REIT for gross proceeds to sellers of $164.7 million
- NYSE-listed utility company in its $1.7 billion public offering of common stock
- Bruker Corporation in its $403 million public offering of common stock
- CoStar Group Inc. in its $862.5 million public offering of common stock; and its $1.5 billion public offering of common stock*
- Replimune Group, Inc. in its $260 million public offering of shares of common stock
- Rocket Pharmaceuticals, Inc. in its $72.875 million public offering of common stock*
- South Jersey Industries Inc. in its $660 million public offering of common stock and equity units*
Debt
- NYSE-listed utility company in connection with its electricity transmission subsidiary’s $600 million Rule 144A/Reg S offering of senior notes
- NYSE-listed utility company in connection with private offerings by its finance subsidiaries of senior notes of $150 million, $200 million, $225 million, and $250 million
- Major private financial services partnership in its private offering of ¥4 billion of senior notes
- Chobani LLC in its $530 million Rule 144A/Reg S offering of senior notes*
- Coeur Mining Inc. in its $250 million Rule 144A/Reg S offering of senior notes and cash tender offers to purchase outstanding senior notes; $375 million Rule 144A/Reg S offering of senior notes and cash tender offers to purchase outstanding senior notes
- Pitney Bowes Inc. in its $750 million Rule 144A/Reg S offering of senior notes and cash tender offers to purchase outstanding senior notes*
- Tenet Healthcare Corporation in its $1.5 billion Rule 144A/Reg S offering of senior notes*
M&A Transactions
- enGene Inc. in connection with its business combination with Forbion European Acquisition Corp., a special purpose acquisition company; gross proceeds from the merger totaled approximately $138 million
- Stem Inc. in connection with its $1.35 billion merger with Star Peak Energy Transition Corp., a special purpose acquisition company*
- Fifth Wall Acquisition Corp. I, a special purpose acquisition company, in its $2.2 billion acquisition of SmartRent Inc.*
- Empower Ltd., a special purpose acquisition company, in connection with its $1.55 billion business combination with Holley Inc.*
- Trecora Resources, in its $247 million sale to an affiliate of Balmoral Funds LLC
- Bruker Corporation in its acquisition of PhenomeX for $108 million
* Note: This list includes engagements completed prior to joining Morgan Lewis.
- Howard University School of Law, 2013, J.D., cum laude
- University of Pennsylvania, 2010, B.A., Philosophy, Politics & Economics (PPE)
- New York
- New Jersey


Recommended, Finance: Capital markets: equity offerings, The Legal 500 US (2025)
Listed, The Best Lawyers in America, Ones to Watch, Securities Regulation, New York (2021–2025)
Member, National Bar Association
Senior Notes & Comments Editor, Howard Law Journal
Member, Kappa Alpha Psi Fraternity Inc.
No aspect of this advertisement has been approved by the Supreme Court of New Jersey. A description of the selection methodology for the above awards can be found here.
